Zdrowie i gospodarka · 7.06.2002
Pharmacy Compounding Compliance Policy Guide; Availability
The Food and Drug Administration (FDA) is announcing the availability of a guidance for FDA staff and industry entitled "Sec. 460.200 Pharmacy Compounding." The document being issued with this notice provides guidance to drug compounders on how FDA intends to address pharmacy compounding as a result of a recent decision by the Supreme Court.